{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001548","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.297555+00:00","generated_at":"2026-05-30T19:19:02.383770+00:00","sec_items":["3.01","5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Virpax receives Nasdaq deficiency notice; CEO and CFO resign citing policy disagreements","bullets":["Nasdaq notified Virpax that its bid price was below $1.00 for 30 consecutive days; compliance deadline April 2, 2025.","CEO Gerald Bruce and CFO Vinay Shah resigned Oct 5 effective immediately, citing disagreements with Board's execution of policies.","Board appointed director Jatinder Dhaliwal as CEO effective Oct 6; Katharyn Field joins audit committee replacing Dhaliwal.","Company may consider a reverse stock split to regain compliance, but no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001548","json":"https://secwatch.observer/filing/0001731122-24-001548.json","markdown":"https://secwatch.observer/filing/0001731122-24-001548.md","text":"https://secwatch.observer/filing/0001731122-24-001548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001548/0001731122-24-001548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001548/e6009_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:19:02.383770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"40c15993d6","claim":"Jatinder Dhaliwal was appointed as Chief Executive Officer at Virpax Pharmaceuticals, Inc..","evidence_excerpt":"On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001548/0001731122-24-001548-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a4fc501f96","claim":"Vinay Shah resigned as Chief Financial Officer at Virpax Pharmaceuticals, Inc..","evidence_excerpt":"On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001548/0001731122-24-001548-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"b965c49c83","claim":"Gerald Bruce resigned as Chief Executive Officer at Virpax Pharmaceuticals, Inc..","evidence_excerpt":"On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001548/0001731122-24-001548-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}